表紙
市場調查報告書

全球上con炎治療市場:治療類型(皮質類固醇注射劑,手術,療法,鎮痛藥,NSAIDS,設備和其他產品),最終用戶,區域趨勢分析,競爭性市場份額和預測(2016年) 2026年)

Lateral Epicondylitis Market by Treatment type (Corticosteroid Injections, Surgery, Therapy, Painkillers and NSAIDS, Equipment's and Other Products, By End User, By Region ; Trend Analysis, Competitive Market Share & Forecast, 2016-26

出版商 Blueweave Consulting & Research Private Limited 商品編碼 948250
出版日期 內容資訊 英文 179 Pages
商品交期: 最快1-2個工作天內
價格
全球上con炎治療市場:治療類型(皮質類固醇注射劑,手術,療法,鎮痛藥,NSAIDS,設備和其他產品),最終用戶,區域趨勢分析,競爭性市場份額和預測(2016年) 2026年) Lateral Epicondylitis Market by Treatment type (Corticosteroid Injections, Surgery, Therapy, Painkillers and NSAIDS, Equipment's and Other Products, By End User, By Region ; Trend Analysis, Competitive Market Share & Forecast, 2016-26
出版日期: 2020年05月01日內容資訊: 英文 179 Pages
簡介

2019年全球外側上con炎市場規模將達到89.53億美元,在2020年至2026年的預測期內以及到1026、10、397、704的複合年均增長率為2.32%預計將達到10,000美元。

由於人口老齡化的增加,外側上con炎的患病率也在增加。已發現感興趣的疾病在老年人中更為常見。由於與生活方式有關的疾病的擴散,預計該市場在不久的將來會出現顯著增長。此外,政府提供信息的努力,例如對老年人的綜合照料,以提高人們對老年人健康的認識,正在推動市場需求。

該報告調查了全球的上con炎治療市場,並提供了諸如行業洞察力,市場概況,區域市場分析以及主要公司概況之類的信息。

內容

第1章調查框架

第2章調查方法

第3章執行摘要

第4章世界上的上epi上炎(網球肘)的真知灼見

  • 產業價值鏈分析
  • DROC分析
    • 生長因子
    • 抑制因子
    • 市場機會
    • 挑戰
  • 主要市場趨勢
  • 全球全球上con骨炎(網球肘)的領先公司分析(2019)
  • 波特的五力分析
  • Covid-19對整個行業的影響

第5章全球顳上con炎(網球肘)市場概述

  • 市場評估/預測:2016-2026年(基於價值)
    • 金額(百萬美元)
  • 市場份額和預測
    • 按治療類型
      • 糖皮質激素注射
      • 手術
      • 療法(衝擊波療法和物理療法)
      • 鎮痛藥和非甾體抗炎藥
      • 設備及其他產品
    • 按最終用戶
      • 醫院/診所
      • 藥房/藥房
    • 按地區
      • 北美
      • 歐洲
      • 亞太地區
      • 拉丁美洲
      • 中東/非洲

第6章:北美外側上con炎(網球肘)治療市場

  • 市場評估和預測:2016-2026(基於價值)
    • 金額(百萬美元)
  • 市場份額和預測
    • 按治療類型
    • 按最終用戶
    • 按國家
      • 美國
      • 加拿大

第7章歐洲上con炎(網球肘)治療市場

  • 市場評估和預測:2016-2026(基於價值)
    • 金額(百萬美元)
  • 市場份額和預測
    • 按治療類型
    • 按最終用戶
    • 按國家
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲

第8章亞太上con炎(網球肘)治療市場

  • 市場評估和預測:2016-2026(基於價值)
    • 金額(百萬美元)
  • 市場份額和預測
    • 按治療類型
    • 按最終用戶
    • 按國家
      • 中國
      • 印度
      • 日本
      • 韓國
      • 亞太地區其他國家

第9章拉丁美洲外側上con炎(網球肘)治療市場

  • 市場評估和預測:2016-2026(基於價值)
    • 金額(百萬美元)
  • 市場份額和預測
    • 按治療類型
    • 按最終用戶
    • 按國家
      • 巴西
      • 墨西哥
      • 其他拉丁美洲

第10章中東和非洲的外側上Epi炎(網球肘)治療市場

  • 市場評估和預測:2016-2026(基於價值)
    • 金額(百萬美元)
  • 市場份額和預測
    • 按治療類型
    • 按最終用戶
    • 按國家
      • 阿拉伯聯合酋長國
      • 沙特阿拉伯
      • 南非
      • 其他

第11章公司簡介(公司簡介,財務矩陣,產品狀況,關鍵人物,關鍵競爭對手,聯繫地址和戰略展望)*

  • Stryker Corporation
  • Smith & Nephew plc
  • Arthrex
  • Zimmer Biomet
  • 生化學工業
  • DJO Global, Inc.
  • Pfizer Inc.
  • 3M Company
  • 中外製藥
  • 帝國製藥
  • 其他
目錄
Product Code: BWC20065

Title:
Lateral Epicondylitis (Tennis Elbow) Market by Treatment type (Corticosteroid Injections, Surgery, Therapy (Shock Wave Therapy & Physical Therapy), Painkillers and NSAIDS, Equipment's and Other Products, By End User (Hospital/Clinic and Pharmacy/Drug Stores), By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2016-26.

The Global Lateral Epicondylitis Market valued USD 8953.51 million in 2019, and projected to reach 10,397.04 by 2026, at a CAGR of 2.32% during the forecast year 2020-2026. The treatment involves medications, braces, physical therapies and extracorporeal shock wave therapy is a type of Non-surgical treatment. Pain in lateral epicondylitis (tennis elbow) is excruciating in severe conditions, which can be controlled by administering non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, aspirin and cortisone are administered to control pain in tennis elbow. Besides the medications, physical therapies such as ice massage or muscle stimulating techniques are utilized to improve healing. In addition, there are braces or strap available in the market, which limits the stress on elbow muscles and tendons. Moreover, extracorporeal shock wave therapy may be tried by a therapist that is intended to promote body's natural healing process. Treatment sector comprises certain surgical procedures recommended for patients not responding to the non-surgical treatment for six to twelve months. Two surgical methods that are performed include open surgery and arthroscopic surgery. Open surgery is the most preferred surgical method globally. Mostly, these surgical methods are outpatient surgeries, with very few cases requiring an overnight stay. Such techniques are readily accepted by medical and patient fraternity. Success rate is however, high with non-surgical treatment methods. According to the American Academy of Orthopedic Surgeons, approximately 80% to 95% of patients achieve success from non-surgical treatment.

Increase in geriatric population base contributing with significant growth rate in global Lateral Epicondylitis market during the forecast period

Increase in geriatric population base also contribute to the prevalence of lateral epicondylitis. The target disease is found to be more prevalent in geriatric population. With an upsurge in lifestyle disorders, the market is anticipated to register significant growth in near future. Moreover, favorable government initiatives such as Integrated Care for Older People to raise the awareness about geriatric health drives the demand for the market.

Tennis elbow is seen in older individuals and is more common in men than in women. Any activity that involves forceful turning of the hand or forceful extension of the wrist can produce tennis elbow. This condition is treated by resting the affected area, avoiding activities that cause pain, and wearing an elbow guard. The tennis elbow facilitates the gliding of muscles and tendons over bony surfaces. The most common joint affected by bursitis is the shoulder, although the elbow, foot, knee, and hand can be affected.

Growing access to insurance & Increasing investment by public as well as private players is an emerging opportunity in global market

The objective is to boost the growth of the global lateral epicondylitis Treatment market by rising healthcare coverage, facilities and investment by both public and private players. In addition, with the rising advancement in sports leads to various insurance provided by authorities to players. Most policies are package policies that combine several individual coverages together so that they can offer protection against multiple risks. Demand for healthcare services, and thus health insurance, is growing due to the aging of the population, increasing cases of Lateral Epicondylitis and Sport-Related Injuries or prevalence of lateral epicondylitis. At the same time, pressure on public finances is driving many governments to implement cuts in spending on healthcare or to seek out private payers as intermediaries to better manage costs and outcomes. Capturing the opportunity requires understanding and responding to four fundamental forces which are transforming the private health-insurance market. The United States is observing mergers between health-care insurance companies and pharmacy chains, especially those with retail clinics.

North America dominating the global Lateral Epicondylitis market with considerable rate in upcoming years

North America dominated the global tennis elbow treatment market in terms of revenue share in 2019. Increasing number of sport events & competitions in the U.S. coupled with increasing patient awareness level are the vital factors for the growth of tennis elbow treatment market in this region. Furthermore, factors such as rising geriatric population, and availability of insurance coverage are projected to drive the regional demand. The presence of leading key players headquarter amidst the region is the key factor driving growth of North America tennis elbow market across the global region. Braces (included in other segment) segment is expected to exhibit lucrative growth over the forecast period owing to the increasing incidence of sports injuries and growing geriatric population. The braces are mostly recommended after ACL injury and for decreasing any additional injury post ACL reconstruction. As per the centers for Disease Control and Prevention, anterior cruciate ligament (ACL) injury affects around 250,000 individuals in the United States annually, resulting in an annual health care cost exceeding $2 billion. Increasing incidence of pneumocccal disease is a high impact rendering driver. It will eventually increase the market for braces.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Breakdown of Primary Research Respondents, By Region
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Breakdown of Primary Research Respondents
  • 2.5. Market Size Estimation
  • 2.6. Assumption for The Study
  • 2.7. Market Breakdown & Data Triangulation

3. Executive Summary

4. Global Lateral Epicondylitis (Tennis Elbow) Insights

  • 4.1. Industry Value Chain Analysis
  • 4.2. DROC Analysis
    • 4.2.1. Growth Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. Market Key Trends
  • 4.4. Global Lateral Epicondylitis (Tennis Elbow) Leading Company Analysis, 2019
  • 4.5. Porter's Five Forces Analysis
  • 4.6. Impact of Covid-19 Across Industry

5. Global Lateral Epicondylitis (Tennis Elbow) Market Overview

  • 5.1. Market Estimates & Forecast by Value, 2016-2026
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Treatment Type
      • 5.2.1.1. Corticosteroid Injections
      • 5.2.1.2. Surgery
      • 5.2.1.3. Therapy (Shock Wave Therapy & Physical Therapy)
      • 5.2.1.4. Painkillers and NSAIDS
      • 5.2.1.5. Equipment's and Other Products
    • 5.2.2. By End User
      • 5.2.2.1. Hospital/Clinic
      • 5.2.2.2. Pharmacy/Drug Stores
    • 5.2.3. By Region
      • 5.2.3.1. North America
      • 5.2.3.2. Europe
      • 5.2.3.3. Asia Pacific
      • 5.2.3.4. Latin America
      • 5.2.3.5. Middle East & Africa

6. North America Lateral Epicondylitis (Tennis Elbow) Market

  • 6.1. Market Estimates & Forecast by Value, 2016-2026
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Treatment Type
    • 6.2.2. By End-User
    • 6.2.3. By Country
      • 6.2.3.1. United States
      • 6.2.3.2. Canada

7. Europe Lateral Epicondylitis (Tennis Elbow) Market

  • 7.1. Market Estimates & Forecast by Value, 2016-2026
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Treatment Type
    • 7.2.2. By End-User
    • 7.2.3. By Country
      • 7.2.3.1. Germany
      • 7.2.3.2. United Kingdom
      • 7.2.3.3. France
      • 7.2.3.4. Italy
      • 7.2.3.5. Spain
      • 7.2.3.6. Rest of Europe

8. Asia Pacific Lateral Epicondylitis (Tennis Elbow) Market

  • 8.1. Market Estimates & Forecast by Value, 2016-2026
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Treatment Type
    • 8.2.2. By End-User
    • 8.2.3. By Country
      • 8.2.3.1. China
      • 8.2.3.2. India
      • 8.2.3.3. Japan
      • 8.2.3.4. South Korea
      • 8.2.3.5. Rest of APAC

9. Latin America Lateral Epicondylitis (Tennis Elbow) Market

  • 9.1. Market Estimates & Forecast by Value, 2016-2026
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Treatment Type
    • 9.2.2. By End-User
    • 9.2.3. By Country
      • 9.2.3.1. Brazil
      • 9.2.3.2. Mexico
      • 9.2.3.3. Rest of Latin America

10. Middle East & Africa Lateral Epicondylitis (Tennis Elbow) Market

  • 10.1. Market Estimates & Forecast by Value, 2016-2026
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Treatment Type
    • 10.2.2. By End-User
    • 10.2.3. By Country
      • 10.2.3.1.UAE
      • 10.2.3.2.Saudi Arabia
      • 10.2.3.3.South Africa
      • 10.2.3.4.Rest of MEA

11. Company Profile (Company Overview, Financial Matrix, Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)*

  • 11.1. Stryker Corporation
  • 11.2. Smith & Nephew plc
  • 11.3. Arthrex
  • 11.4. Zimmer Biomet
  • 11.5. Seikagaku Corporation
  • 11.6. DJO Global, Inc.
  • 11.7. Pfizer Inc.
  • 11.8. 3M Company
  • 11.9. Chugai Pharmaceutical Co., Ltd
  • 11.10.Teikoku Seiyaku Co., Ltd.
  • 11.11.Other Prominent Players